| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.94B | 35.71B | 36.29B | 33.13B | 28.09B | 22.93B |
| Gross Profit | 6.23B | 6.50B | 7.46B | 6.56B | 5.16B | 3.66B |
| EBITDA | 7.05B | 7.15B | 8.07B | 7.54B | 6.43B | 4.62B |
| Net Income | 3.31B | 3.35B | 4.46B | 4.20B | 3.44B | 1.88B |
Balance Sheet | ||||||
| Total Assets | 54.53B | 54.87B | 48.94B | 47.96B | 43.13B | 41.51B |
| Cash, Cash Equivalents and Short-Term Investments | 3.39B | 4.21B | 4.67B | 3.99B | 2.89B | 3.14B |
| Total Debt | 11.61B | 12.31B | 12.07B | 11.96B | 12.23B | 14.20B |
| Total Liabilities | 27.17B | 27.58B | 26.59B | 26.60B | 25.15B | 26.23B |
| Stockholders Equity | 26.18B | 26.11B | 21.13B | 20.19B | 17.68B | 15.00B |
Cash Flow | ||||||
| Free Cash Flow | 4.68B | 4.79B | 4.47B | 4.54B | 2.00B | 3.47B |
| Operating Cash Flow | 6.32B | 6.49B | 6.60B | 6.64B | 3.72B | 4.65B |
| Investing Cash Flow | -947.00M | -1.41B | -3.15B | -2.78B | -1.39B | -919.00M |
| Financing Cash Flow | -5.50B | -5.64B | -2.77B | -2.51B | -2.38B | -2.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $33.47B | 11.13 | 11.48% | 4.43% | -3.95% | 2.15% | |
79 Outperform | $68.46B | 16.25 | 16.84% | 2.04% | 0.20% | 6.96% | |
78 Outperform | $29.74B | 26.54 | 29.62% | 0.44% | 9.44% | 36.97% | |
75 Outperform | $83.17B | 25.61 | 13.46% | 2.98% | -0.53% | -22.59% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
62 Neutral | $35.07B | 17.70 | 14.67% | 2.41% | -1.72% | -23.60% | |
59 Neutral | $7.16B | 84.88 | 1.43% | 3.24% | -1.33% | -84.10% |